Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.885
-0.105 (-5.28%)
Mar 31, 2025, 1:37 PM EDT - Market open

Prime Medicine Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
2.98---5.21
Upgrade
Cost of Revenue
155.29147.9186.7370.552.98
Upgrade
Gross Profit
-152.31-147.91-86.73-70.552.23
Upgrade
Selling, General & Admin
50.1643.3929.8213.923.16
Upgrade
Operating Expenses
50.1643.3929.8213.923.16
Upgrade
Operating Income
-202.47-191.29-116.54-84.47-0.93
Upgrade
Interest & Investment Income
3.522.81---
Upgrade
Other Non Operating Income (Expenses)
0.040.271.9-80.99-11.48
Upgrade
EBT Excluding Unusual Items
-198.9-188.21-114.64-165.46-12.41
Upgrade
Gain (Loss) on Sale of Investments
3.023.3-8.13-0.3910.87
Upgrade
Other Unusual Items
--13.5---
Upgrade
Pretax Income
-195.88-198.41-122.77-165.85-1.54
Upgrade
Income Tax Expense
--0.28-0.95-0.491.87
Upgrade
Net Income
-195.88-198.13-121.82-165.37-3.41
Upgrade
Preferred Dividends & Other Adjustments
--20.1918.751.65
Upgrade
Net Income to Common
-195.88-198.13-142.01-184.12-5.06
Upgrade
Shares Outstanding (Basic)
1199134133
Upgrade
Shares Outstanding (Diluted)
1199134133
Upgrade
Shares Change (YoY)
30.37%168.41%161.23%391.47%77.53%
Upgrade
EPS (Basic)
-1.65-2.18-4.19-14.19-1.91
Upgrade
EPS (Diluted)
-1.65-2.18-4.19-14.19-1.91
Upgrade
Free Cash Flow
-130.16-174.14-147.92-38.23-6.18
Upgrade
Free Cash Flow Per Share
-1.10-1.91-4.37-2.95-2.34
Upgrade
Gross Margin
----42.80%
Upgrade
Operating Margin
-6787.36%----17.89%
Upgrade
Profit Margin
-6566.61%----97.02%
Upgrade
Free Cash Flow Margin
-4363.36%----118.68%
Upgrade
EBITDA
-196.34-186.64-114.32-83.91-0.89
Upgrade
EBITDA Margin
-----17.06%
Upgrade
D&A For EBITDA
6.134.652.220.570.04
Upgrade
EBIT
-202.47-191.29-116.54-84.47-0.93
Upgrade
EBIT Margin
-----17.89%
Upgrade
Revenue as Reported
2.98----
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q